Literature DB >> 17239296

Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction.

Ann H Klopp1, Georgie A Eapen, Ritsuko R Komaki.   

Abstract

Symptoms resulting from tumors extending to the endobronchial wall are common in patients with lung cancer and significantly impact quality of life. A number of treatment options are available for palliation, including endobronchial brachytherapy, stent placement, laser photoresection, external-beam radiation therapy, and photodynamic therapy. This review will focus on the methodology and role of endobronchial brachytherapy while discussing benefits of other treatment options as additions or alternatives to brachytherapy.

Entities:  

Mesh:

Year:  2006        PMID: 17239296     DOI: 10.3816/CLC.2006.n.048

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  4 in total

Review 1.  Minimally invasive palliative interventions in advanced lung cancer.

Authors:  Christopher Mallow; Margaret Hayes; Roy Semaan; Thomas Smith; Russell Hales; Roy Brower; Lonny Yarmus
Journal:  Expert Rev Respir Med       Date:  2018-06-19       Impact factor: 3.772

2.  Functional airway obstruction observed with hyperpolarized 129 Xenon-MRI.

Authors:  Erin J Song; Chris R Kelsey; Bastiaan Driehuys; Leith Rankine
Journal:  J Med Imaging Radiat Oncol       Date:  2017-09-22       Impact factor: 1.735

3.  The efficacy of external beam radiotherapy for airway obstruction in lung cancer patients.

Authors:  Jeong Won Lee; Jong Hoon Lee; Hoon-Kyo Kim; Byoung Yong Shim; Ho Jung An; Sung Hwan Kim
Journal:  Cancer Res Treat       Date:  2014-09-12       Impact factor: 4.679

4.  A Novel Tracheobronchial Stent Loaded with 125I Seeds in Patients with Malignant Airway Obstruction Compared to a Conventional Stent: A Prospective Randomized Controlled Study.

Authors:  Yong Wang; Jian Lu; Jin-He Guo; Guang-Yu Zhu; Hai-Dong Zhu; Li Chen; Chao Wang; Gao-Jun Teng
Journal:  EBioMedicine       Date:  2018-06-14       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.